Tweets
Single center study of individualized anakinra use in 47 autoinflammatory pts (32kids; 43% MAS; 40% systemic JIA). Off-label use in 38%, higher doses in 21 kids (5-29mg/kg); & 5 given IV anakinra; such doses were well tolerated without major AE. https://t.co/wQgw3YAPKX https://t.co/zL3HfdX4Ns
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Juvenile CADM: JAMA Case - 6 yoF with 4 yrs of rash on hands, feet, elbows, knees. No Resp to topicals. ROS rare cough & SOB; no weakness. Gottrons over hands, knee. Bx +, ANA+ 1:320, nl enzymes, MSA- See how she was Rx https://t.co/l26Y666JKZ https://t.co/XlzWNKILJU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Good review of Diagnosis and Treatment of Pulmonary Sarcoidosis in JAMA.
- Lung progression (in only 10%) assoc w/ 12-18% 5yr mortality
- Sx Sarcoid w/ Lung: start Pred 20 to 40 mg/d for 2 -6 wks
- Steroid sparing w/ MTX, AZA or TNFi https://t.co/ylF8KR47gc https://t.co/VUvjYYC8gG
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Shared Decision Making in PsA
Changing to a new biologic or sticking with the old one - a PsA patient chooses
QD Clinic is sponsored by https://t.co/4UQlqwujiR
(March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/Hc7ctWtj7A https://t.co/BAApPkxefc
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
We are excited to announce that Dr. Philip Mease will be joining us at RheumNow Live, leading a presentation and discussion on Axial Psoriatic Arthritis & Fatigue and Central Sensitization.
Join the discussion on March 19-20, on site or virtually!
https://t.co/AIteIEHY9E https://t.co/ybXhIelSgM
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Gout is common but disproportionately affects certain groups (e.g., the elderly, Pacific Islander, Blacks). Ethnic links to gout were also recently shown to be linked to modifiable behavioral factors that may prove useful in managing gout patients.
https://t.co/uvIuw3zFnq https://t.co/EZomBGQIyt
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Study of 155 adult patients (PsA 61/AS 94) looked at labs & CV risk factors; found IL-18 elevated in peripheral PsA more than axial PsA & AS. Elevations were higher in PsA pts w/ ischemic heart disease correlated w/ atherogenic index & TG levels https://t.co/PQ3fBi8Qdo https://t.co/mewrcwhi4o
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Another Kind of COVID Discussion
Another kind of COVID (vaccination) discussion - kindness and respect for the patient
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/XkUkqQ1Vli https://t.co/lrPd6jBMjt
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 Patients
https://t.co/nUrAikqyPS https://t.co/CfmyB7Wwb6
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Download this week’s podcast titled “When Less (Drug) is More (Activity) “
https://t.co/omdC3fElsb https://t.co/Hva4h9yEa9
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
ACR Guidelines for the Treatment of Systemic Juvenile Idiopathic Arthritis
The ACR has updated its clinical guidelines for the management of JIA, with this update focusing on oligoarthritis, TMJ arthritis, and systemic JIA.
https://t.co/eKv8qubl1v https://t.co/xLBMccCYex
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
COMPLETE-PsA Trial studied MTX vs MTX + leflunomide in 78 active untreated PsA pts. MTX+LEF was superior to MTX alone at wk 16 (PASDAS 3·1 vs 3·7; p=0·025). Combo group had more N/V (44% v 28%), ^ALT (31% vs 18%). https://t.co/Hc4rNrlQzP https://t.co/UPosZIc4C0
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago


